SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-139694
Filing Date
2018-04-30
Accepted
2018-04-27 19:10:55
Documents
6
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A d533204ddefa14a.htm DEFA14A 46440
2 GRAPHIC g533204snap0001.jpg GRAPHIC 1817
3 GRAPHIC g533204snap0003.jpg GRAPHIC 1468
4 GRAPHIC g533204snap0004.jpg GRAPHIC 2112
5 GRAPHIC g533204snap0005.jpg GRAPHIC 1790
6 GRAPHIC g533204snap0006.jpg GRAPHIC 1810
  Complete submission text file 0001193125-18-139694.txt   60556
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36544 | Film No.: 18786164
SIC: 2834 Pharmaceutical Preparations